Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
-3°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hepion Pharmaceuticals, Inc. - Common Stock
(NQ:
HEPA
)
0.1831
-0.0195 (-9.62%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Hepion Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
Next >
These stocks are moving in today's after hours session
January 28, 2025
After the conclusion of the US market's regular session on Tuesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
January 28, 2025
Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Via
Chartmill
Unusual volume stocks are being observed in Tuesday's session.
January 28, 2025
Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.
Via
Chartmill
The market is filled with gapping stocks in Tuesday's session.
January 28, 2025
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Get insights into the top gainers and losers of Tuesday's pre-market session.
January 28, 2025
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 28, 2025
Via
Benzinga
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
January 28, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday?
January 27, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
On Friday, there are stocks with unusual volume. Let's take a look.
January 24, 2025
These stocks have an unusual volume in today's session
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 23, 2025
Via
Benzinga
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
January 22, 2025
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings
January 22, 2025
Via
Benzinga
US Stocks Higher; Netflix Profit Beats Estimates
January 22, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
October 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 18, 2024
Via
Benzinga
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q2 2024
August 13, 2024
Hepion Pharmaceuticals just reported results for the second quarter of 2024.
Via
InvestorPlace
Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer
July 22, 2024
Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease treatment. The merger values Hepion at $58.5 million, and Pharma Two B plans...
Via
Benzinga
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q1 2024
May 21, 2024
Hepion Pharmaceuticals just reported results for the first quarter of 2024.
Via
InvestorPlace
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
April 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
April 22, 2024
Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progression and strategic alternatives.
Via
Benzinga
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 22, 2024
Via
Benzinga
Gold Falls Sharply; Matterport Shares Spike Higher
April 22, 2024
Via
Benzinga
Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts
April 22, 2024
Nike layoffs are on the way as the athletic wear company is preparing to cut 740 jobs in two rounds at its global headquarters.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In March
April 22, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?
April 22, 2024
Hepion Pharmaceuticals stock is falling on Monday as investors in HEPA learn of the company winding down a Phase 2b clinical trial.
Via
InvestorPlace
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.